Lipoflex (Valine, Alanine, Arginine, Isoleucine, Leucine, Methionine, Phenylalanine, Proline, Serine, Threonin)

The blend supplies essential and non‑essential amino acids directly into the bloodstream, bypassing the digestive tract. These amino acids serve as substrates for protein synthesis, help maintain nitrogen balance, and support metabolic pathways involved in wound healing, immune function, and energy production during catabolic stress.

The dose of Lipoflex is individualized by the prescribing clinician based on the patient’s weight, metabolic needs, and clinical condition. Healthcare professionals calculate the appropriate volume and infusion rate to meet the specific nutritional requirements of each patient.

Safety data for Lipoflex in pregnancy and lactation are limited. It should only be used if the potential benefit to the mother outweighs any possible risk to the fetus or infant, and the decision must be made by a qualified healthcare provider.

To order Lipoflex, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India works with hospitals, pharmacies, and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including cold‑chain handling if needed), and necessary import documentation.

Lipoflex offers a comprehensive amino acid profile that matches many standard parenteral nutrition formulations. Compared with products that contain fewer amino acids, Lipoflex may provide a more balanced supply of essential and non‑essential amino acids, potentially reducing the need for additional supplementation.

Lipoflex must be stored at 2‑8 °C, protected from light, and kept in its original packaging. It should not be frozen or shaken. Before administration, inspect the solution for particulate matter or discoloration and allow it to reach room temperature if required by the infusion protocol.

Lipoflex is administered intravenously, typically as an infusion through a peripheral or central line. The infusion rate and total volume are determined by the prescribing clinician, and the solution should be delivered using aseptic technique in accordance with institutional protocols.

Serious risks include anaphylactic reactions, severe metabolic acidosis, and renal dysfunction. Patients should be monitored closely for signs of hypersensitivity, abrupt changes in blood pH, or impaired kidney function during and after infusion.

Lipoflex should be avoided in patients with known hypersensitivity to any of its amino acid components, those with uncontrolled severe renal or hepatic impairment, and individuals receiving conflicting high‑dose nitrogen‑containing therapies unless closely monitored by a specialist.